Back to search
Perimenopause
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Perimenopause trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Perimenopause trials you may qualify forThe purpose of this study is to identify the impact of estradiol (E2) on the associations between (a) responsivity to daily stress or (b) sleep variability with…
This proposal will examine the effects of estradiol administration on perimenopausal-onset (PO) anhedonia and psychosis symptoms as well as on brain function us…
Perimenopause is now considered a possible risk factor for dementia and may contribute to the fact that 2/3 of those living with Alzheimer's disease are females…
This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control a…
This study aims to investigate the effect that a structured, progressive resistance exercise program may have on maintaining the muscle mass and physical functi…
The aim of this clinical trial is to determine if resistance training and a newly developed plant-based nutritional supplement can improve the symptoms and musc…
The goal of this consumer study is to evaluate the efficacy of a postbiotic supplement on menopausal symptoms and hormonal balance in premenopausal women ages 3…
The purpose of this sequential exploratory mixed-methods study is to examine the relationship between perimenopausal symptom severity and occupational performan…
The purpose of this study is to identify the impact of estradiol (E2) on the mechanisms that regulate vascular endothelial function in peri-menopausal (PERI) wo…